Showing results (91-100 of 280) with videos related to
Sort By:
Pageof 28
The Oncologist|July 31, 2024
Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancerMehmet A Bilen, Ibrahim Khilfeh, Carmine Rossi, et al.AJR. American Journal of Roentgenology|April 12, 2016
Can Radiologic Staging With Multiparametric MRI Enhance the Accuracy of the Partin Tables in Predicting Organ-Confined Prostate Cancer?Rajan T Gupta, Alison Flanagan Brown, Rachel Kloss Silverman, et al.Journal of Oncology Practice|November 28, 2013
Real-world outcomes in metastatic renal cell carcinoma: insights from a Joint Community-Academic RegistryMichael R Harrison, Bradford R Hirsch, Daniel J George, et al.Current Medical Research and Opinion|December 17, 2013
Comparative outcomes of everolimus, temsirolimus and sorafenib as second targeted therapies for metastatic renal cell carcinoma: a US medical record reviewMichael K Wong, Hongbo Yang, James E Signorovitch, et al.Journal of Hematology & Oncology|October 29, 2020
Novel therapies are changing treatment paradigms in metastatic prostate cancerEric Powers, Georgia Sofia Karachaliou, Chester Kao, et al.JCO Precision Oncology|August 18, 2023
Transcriptomic Signatures Associated With Outcomes in Recurrent Prostate Cancer Treated With Salvage Radiation, Androgen-Deprivation Therapy, and Enzalutamide: Correlative Analysis of the STREAM TrialRhonda L Bitting, Yuan Wu, Jason A Somarelli, et al.Prostate Cancer and Prostatic Diseases|February 22, 2021
Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetateScott T Tagawa, Krishnan Ramaswamy, Ahong Huang, et al.Medical Oncology (Northwood, London, England)|August 14, 2014
Use of "Real-World" data to describe adverse events during the treatment of metastatic renal cell carcinoma in routine clinical practiceBradford R Hirsch, Michael R Harrison, Daniel J George, et al.Clinical Genitourinary Cancer|March 13, 2019
Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell CarcinomaMatthew K Labriola, Kristen A Batich, Jason Zhu, et al.Molecular Cancer Research : MCR|March 27, 2021
Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate CancerSantosh Gupta, Susan Halabi, Gabor Kemeny, et al.Pageof 28